Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration.
Clinical trial NCT06180382 · RECRUITING
Trial details
- NCT number
- NCT06180382
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-31
- Primary completion
- 2027-10-31
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.